ATE492537T1 - Verbindungen mit aktivität am m1-rezeptor und ihre verwendung in der medizin - Google Patents
Verbindungen mit aktivität am m1-rezeptor und ihre verwendung in der medizinInfo
- Publication number
- ATE492537T1 ATE492537T1 AT06794584T AT06794584T ATE492537T1 AT E492537 T1 ATE492537 T1 AT E492537T1 AT 06794584 T AT06794584 T AT 06794584T AT 06794584 T AT06794584 T AT 06794584T AT E492537 T1 ATE492537 T1 AT E492537T1
- Authority
- AT
- Austria
- Prior art keywords
- medicine
- compounds
- receptor activity
- receptor
- activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0519950.0A GB0519950D0 (en) | 2005-09-30 | 2005-09-30 | Compounds |
GB0602040A GB0602040D0 (en) | 2006-02-01 | 2006-02-01 | Compounds |
PCT/GB2006/003590 WO2007036715A2 (en) | 2005-09-30 | 2006-09-27 | Compounds which have activity at m1 receptor and their uses in medicine |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE492537T1 true ATE492537T1 (de) | 2011-01-15 |
Family
ID=37598231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06794584T ATE492537T1 (de) | 2005-09-30 | 2006-09-27 | Verbindungen mit aktivität am m1-rezeptor und ihre verwendung in der medizin |
Country Status (24)
Country | Link |
---|---|
US (2) | US8283364B2 (de) |
EP (1) | EP1943230B1 (de) |
JP (1) | JP5209480B2 (de) |
KR (2) | KR20130091791A (de) |
CN (1) | CN101321736B (de) |
AR (1) | AR056103A1 (de) |
AT (1) | ATE492537T1 (de) |
AU (1) | AU2006296369B2 (de) |
BR (1) | BRPI0616609A2 (de) |
CA (1) | CA2624504C (de) |
CR (1) | CR9904A (de) |
DE (1) | DE602006019119D1 (de) |
EA (1) | EA016286B1 (de) |
IL (1) | IL190219A (de) |
JO (1) | JO2634B1 (de) |
MA (1) | MA29849B1 (de) |
MY (1) | MY148504A (de) |
NO (1) | NO20081945L (de) |
NZ (1) | NZ566508A (de) |
PE (1) | PE20070490A1 (de) |
TW (1) | TWI389905B (de) |
UA (1) | UA101299C2 (de) |
WO (1) | WO2007036715A2 (de) |
ZA (1) | ZA200802167B (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA101299C2 (uk) | 2005-09-30 | 2013-03-25 | Глаксо Груп Лімітед | Сполуки, що мають активність стосовно рецепторів м1, та їх застосування в медицині |
US8288412B2 (en) * | 2005-09-30 | 2012-10-16 | Glaxo Group Limited | Compounds which have activity at M1 receptor and their uses in medicine |
US8288413B2 (en) * | 2005-09-30 | 2012-10-16 | Glaxo Group Limited | Benzimidazolones which have activity at M1 receptor |
US7766829B2 (en) * | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
GB0605785D0 (en) * | 2006-03-22 | 2006-05-03 | Glaxo Group Ltd | Compounds |
GB0706164D0 (en) * | 2007-03-29 | 2007-05-09 | Glaxo Group Ltd | Compounds |
GB0706174D0 (en) * | 2007-03-29 | 2007-05-09 | Glaxo Group Ltd | Compounds |
GB0706165D0 (en) * | 2007-03-29 | 2007-05-09 | Glaxo Group Ltd | Compounds |
GB0706170D0 (en) * | 2007-03-29 | 2007-05-09 | Glaxo Group Ltd | Compounds |
GB0718415D0 (en) * | 2007-09-20 | 2007-10-31 | Glaxo Group Ltd | Compounds |
WO2009124882A1 (en) * | 2008-04-09 | 2009-10-15 | H. Lundbeck A/S | Novel piperidinyl-1,3-dihydro-benzoimidazol-2-ones as m1 agonists |
GB0817982D0 (en) | 2008-10-01 | 2008-11-05 | Glaxo Group Ltd | Compounds |
US20170333407A1 (en) * | 2014-11-03 | 2017-11-23 | William Beaumont Hospital | Method for treating underactive bladder syndrome |
US10604484B2 (en) * | 2015-04-29 | 2020-03-31 | Janssen Pharmaceutica Nv | Indolone compounds and their use as AMPA receptor modulators |
EP3288940B9 (de) | 2015-04-29 | 2021-07-21 | Janssen Pharmaceutica NV | Azabenimidazole und ihre verwendung als ampa-rezeptor-modulatoren |
WO2017044693A1 (en) | 2015-09-11 | 2017-03-16 | Chase Pharmaceuticals Corporation | Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system |
CN107673994A (zh) * | 2017-04-27 | 2018-02-09 | 联化科技股份有限公司 | 一种芳基甲烷类化合物的制备方法 |
CN107739342B (zh) * | 2017-11-29 | 2020-01-10 | 华南理工大学 | 一种一步合成5-二芳氨基苯并咪唑酮衍生物的方法 |
CN117049938A (zh) * | 2023-06-20 | 2023-11-14 | 山东轩德医药科技有限公司 | 一种6-溴-2,3-二氟甲苯的制备方法 |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3161645A (en) | 1962-12-18 | 1964-12-15 | Res Lab Dr C Janssen N V | 1-(1-aroylpropyl-4-piperidyl)-2-benzimidazolinones and related compounds |
US3989707A (en) * | 1974-06-21 | 1976-11-02 | Janssen Pharmaceutica N.V. | Benzimidazolinone derivatives |
US4292321A (en) | 1979-05-24 | 1981-09-29 | Warner-Lambert Company | 1,3,8-Triazaspirodecane-4-ones, pharmaceutical compositions thereof and method of use thereof |
DE3124366A1 (de) * | 1981-06-20 | 1982-12-30 | Hoechst Ag, 6000 Frankfurt | N-oxacyclyl-alkylpiperidin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische praeparate und deren verwendung |
DE4040300A1 (de) | 1990-12-17 | 1992-07-02 | Leifeld Gmbh & Co | Drueckmaschine mit wenigstens einem rollenhalter |
JP3916093B2 (ja) * | 1993-09-17 | 2007-05-16 | 杏林製薬株式会社 | 光学活性イミダゾリジノン誘導体とその製造方法 |
US5691323A (en) * | 1995-05-12 | 1997-11-25 | Merck & Co., Inc. | Muscarine antagonists |
WO1996013262A1 (en) * | 1994-10-27 | 1996-05-09 | Merck & Co., Inc. | Muscarine antagonists |
US5574044A (en) | 1994-10-27 | 1996-11-12 | Merck & Co., Inc. | Muscarine antagonists |
WO1997016186A1 (en) | 1995-10-31 | 1997-05-09 | Merck & Co., Inc. | Muscarine agonists |
US5718912A (en) | 1996-10-28 | 1998-02-17 | Merck & Co., Inc. | Muscarine agonists |
US5977134A (en) | 1996-12-05 | 1999-11-02 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US6465484B1 (en) | 1997-09-26 | 2002-10-15 | Merck & Co., Inc. | Angiogenesis inhibitors |
US6162804A (en) | 1997-09-26 | 2000-12-19 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
AU2307999A (en) | 1997-12-23 | 1999-07-12 | Alcon Laboratories, Inc. | Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions |
ATE275141T1 (de) | 1999-10-13 | 2004-09-15 | Banyu Pharma Co Ltd | Substituierte imidazolin-derivate |
SE9904652D0 (sv) | 1999-12-17 | 1999-12-17 | Astra Pharma Prod | Novel Compounds |
EP1263754A1 (de) | 2000-02-01 | 2002-12-11 | Millennium Pharmaceuticals, Inc. | Indalon und benzimidazolon inhibitoren des faktors xa |
ES2312616T3 (es) | 2001-04-18 | 2009-03-01 | Euro-Celtique S.A. | Compuestos de bencimidazolona. |
US7164024B2 (en) | 2001-04-20 | 2007-01-16 | Banyu Pharmaceutical Co., Ltd. | Benzimidazolone derivatives |
US6951849B2 (en) | 2001-10-02 | 2005-10-04 | Acadia Pharmaceuticals Inc. | Benzimidazolidinone derivatives as muscarinic agents |
EP1432420B1 (de) | 2001-10-02 | 2011-07-13 | Acadia Pharmaceuticals Inc. | Benzimidazolidinon-derivate als muscarinische mittel |
WO2004089942A2 (en) | 2001-10-02 | 2004-10-21 | Acadia Pharmaceuticals Inc. | Benzimidazolidinone derivatives as muscarinic agents |
US7244744B2 (en) | 2001-11-01 | 2007-07-17 | Icagen, Inc. | Piperidines |
US7566728B2 (en) | 2002-03-29 | 2009-07-28 | Mitsubishi Tanabe Pharma Corporation | Remedy for sleep disturbance |
EP1515722A4 (de) | 2002-06-17 | 2006-06-21 | Merck & Co Inc | Ophthalmische zusammensetzungen zur behandlung der okularen hypertonie |
US7645771B2 (en) | 2002-12-13 | 2010-01-12 | Smithkline Beecham Corp. | CCR5 antagonists as therapeutic agents |
JP2005102133A (ja) | 2003-04-28 | 2005-04-14 | Ricoh Co Ltd | 画像形成装置及び宛先情報参照方法 |
BRPI0412809A (pt) | 2003-07-23 | 2006-09-26 | Wyeth Corp | compostos de sulfonildihidrobenzimidazolona como ligantes a 5-hidróxitriptamina-6 |
ES2377484T3 (es) | 2003-09-03 | 2012-03-28 | Pfizer, Inc. | Compuestos de bencimidazolona que tiene actividad agonista del receptor 5-HT |
WO2006048754A1 (en) | 2004-11-02 | 2006-05-11 | Pfizer Japan Inc. | Sulfonyl benzimidazole derivatives |
US7300947B2 (en) | 2005-07-13 | 2007-11-27 | Banyu Pharmaceutical Co., Ltd. | N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives |
UA101299C2 (uk) | 2005-09-30 | 2013-03-25 | Глаксо Груп Лімітед | Сполуки, що мають активність стосовно рецепторів м1, та їх застосування в медицині |
US8288412B2 (en) | 2005-09-30 | 2012-10-16 | Glaxo Group Limited | Compounds which have activity at M1 receptor and their uses in medicine |
US8288413B2 (en) | 2005-09-30 | 2012-10-16 | Glaxo Group Limited | Benzimidazolones which have activity at M1 receptor |
CN101511222B (zh) | 2006-09-08 | 2012-11-14 | 吉莱特公司 | 具有多种刷毛状态的牙刷 |
GB0706190D0 (en) | 2007-03-29 | 2007-05-09 | Glaxo Group Ltd | Compounds |
GB0706189D0 (en) | 2007-03-29 | 2007-05-09 | Glaxo Group Ltd | Compounds |
GB0706174D0 (en) | 2007-03-29 | 2007-05-09 | Glaxo Group Ltd | Compounds |
GB0706167D0 (en) | 2007-03-29 | 2007-05-09 | Glaxo Group Ltd | Compounds |
GB0706168D0 (en) | 2007-03-29 | 2007-05-09 | Glaxo Group Ltd | Compounds |
GB0706165D0 (en) | 2007-03-29 | 2007-05-09 | Glaxo Group Ltd | Compounds |
GB0706187D0 (en) | 2007-03-29 | 2007-05-09 | Glaxo Group Ltd | Compounds |
GB0706170D0 (en) | 2007-03-29 | 2007-05-09 | Glaxo Group Ltd | Compounds |
GB0706173D0 (en) | 2007-03-29 | 2007-05-09 | Glaxo Group Ltd | Compounds |
GB0706188D0 (en) | 2007-03-29 | 2007-05-09 | Glaxo Group Ltd | Compounds |
GB0706164D0 (en) | 2007-03-29 | 2007-05-09 | Glaxo Group Ltd | Compounds |
-
2006
- 2006-09-27 UA UAA200803937A patent/UA101299C2/uk unknown
- 2006-09-27 AU AU2006296369A patent/AU2006296369B2/en not_active Ceased
- 2006-09-27 JP JP2008532866A patent/JP5209480B2/ja not_active Expired - Fee Related
- 2006-09-27 EP EP06794584A patent/EP1943230B1/de active Active
- 2006-09-27 NZ NZ566508A patent/NZ566508A/en not_active IP Right Cessation
- 2006-09-27 EA EA200801001A patent/EA016286B1/ru not_active IP Right Cessation
- 2006-09-27 AT AT06794584T patent/ATE492537T1/de not_active IP Right Cessation
- 2006-09-27 CN CN2006800451692A patent/CN101321736B/zh not_active Expired - Fee Related
- 2006-09-27 CA CA2624504A patent/CA2624504C/en not_active Expired - Fee Related
- 2006-09-27 BR BRPI0616609-1A patent/BRPI0616609A2/pt not_active IP Right Cessation
- 2006-09-27 MY MYPI20080901A patent/MY148504A/en unknown
- 2006-09-27 DE DE602006019119T patent/DE602006019119D1/de active Active
- 2006-09-27 KR KR1020137020049A patent/KR20130091791A/ko not_active Application Discontinuation
- 2006-09-27 WO PCT/GB2006/003590 patent/WO2007036715A2/en active Application Filing
- 2006-09-27 US US12/088,465 patent/US8283364B2/en not_active Expired - Fee Related
- 2006-09-27 KR KR1020087007797A patent/KR101374458B1/ko not_active IP Right Cessation
- 2006-09-28 JO JO2006342A patent/JO2634B1/en active
- 2006-09-28 TW TW095135887A patent/TWI389905B/zh not_active IP Right Cessation
- 2006-09-28 PE PE2006001183A patent/PE20070490A1/es not_active Application Discontinuation
- 2006-09-28 AR ARP060104268A patent/AR056103A1/es unknown
-
2007
- 2007-09-10 US US11/852,455 patent/US8481566B2/en not_active Expired - Fee Related
-
2008
- 2008-03-17 IL IL190219A patent/IL190219A/en not_active IP Right Cessation
- 2008-04-04 MA MA30812A patent/MA29849B1/fr unknown
- 2008-04-18 CR CR9904A patent/CR9904A/es unknown
- 2008-04-23 NO NO20081945A patent/NO20081945L/no not_active Application Discontinuation
-
2009
- 2009-03-07 ZA ZA200802167A patent/ZA200802167B/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE492537T1 (de) | Verbindungen mit aktivität am m1-rezeptor und ihre verwendung in der medizin | |
ATE468326T1 (de) | Verbindungen zur verstärkung der glutamatrezeptorwirkung und deren verwendung in der medizin | |
DE602005023681D1 (de) | Infrarotabsorbierende Verbindungen und deren Verwendung in Bildaufzeichnungselementen | |
ATE473229T1 (de) | Tricyclische verbindungen und deren verwendung als mglur1-antagonisten | |
DE602006017566D1 (de) | Glucopyranosyl-substituierte benzyl-derivate, medikamente mit solchen verbindungen, ihre verwendung und herstellungsverfahren dafür | |
ATE381335T1 (de) | 2-cyanopyrrolopyrimidine und deren pharmazeutische verwendung | |
ATE530553T1 (de) | Zytotoxische mittel mit neuen tomamycin-derivaten und ihre therapeutische verwendung | |
DE502005007106D1 (de) | Substituierte phenylaminothiazole und ihre verwendung | |
ATE440093T1 (de) | 1-alkinyl-2-aryloxyalkylamide und ihre verwendung als fungizide | |
DE602006018225D1 (de) | Filterelement und Filtervorrichtung mit dem genannten Filterelement | |
ATE511507T1 (de) | Piperidinylcarbonylpyrrolidine und deren verwendung als melanocortinagonisten | |
DE602006007049D1 (de) | Heizelement und Heizvorrichtung mit Heizelementen | |
DE602005007546D1 (de) | Kombiniertes Screening-System mit Röntgenstrahlendiffraktion und Ramanspektroskopie | |
ATE543808T1 (de) | 5,6-ring-annelierte indolderivate und ihre verwendung | |
DE602007012308D1 (de) | Bicyclische pyrimidinone und deren verwendung | |
ATE547002T1 (de) | Pestizide und ihre verwendung | |
ATE517867T1 (de) | Verbindungen, die den glutamatrezeptor verstärken und anwendungen davon in der medizin | |
ATE454377T1 (de) | 2-phenyl-6-aminocarbonylpyrimidinderivate und ihre verwendung als antagonisten am p2y12- rezeptor | |
ATE478059T1 (de) | Cinnamoylpiperazinderivate und ihre verwendung als par-1-antagonisten | |
ATE442366T1 (de) | Oxazolidinonderivate und ihre verwendung als antibiotika | |
ATE555097T1 (de) | 4-cycloalkyl-substituierte tetrahydrochinolinderivate und deren verwendung als medikamente | |
DE602004003030D1 (de) | Infrarot-absorbierende verbindungen und ihre verwendung in bebilderbaren elementen | |
ATE399767T1 (de) | 1-phenyl- und 1-pyridylpyrazolderivate und deren verwendung als pestizide | |
DE602006002887D1 (de) | Tricyclische azolderivate, ihre herstellung und ihre verwendung als pharmazeutische mittel | |
DE602006008025D1 (de) | Amidverbindungen und deren verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |